Beta-Hydroxyisovaleric acid

CAS No. 625-08-1

Beta-Hydroxyisovaleric acid( —— )

Catalog No. M15365 CAS No. 625-08-1

Used as pharmaceutical intermediates.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 44 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 39 In Stock
1G 54 In Stock

Biological Information

  • Product Name
    Beta-Hydroxyisovaleric acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Used as pharmaceutical intermediates.
  • Description
    Used as pharmaceutical intermediates.
  • In Vitro
    The reduced activity of methylcrotonyl-CoA carboxylase (MCC) leads to an elevated excretion of 3-methylcrotonic acid, the product of its hydration (3-hydroxyisovaleric acid: 3-HIA), and 3-methylcrotonylglycine, formed by conjugation with glycine.
  • In Vivo
    In male mice (ICR/Jcl) at 8 weeks of age fed the biotin-deficient diet for 6 weeks, the concentration of urinary 3-Hydroxyisovaleric acid is 114.2 mM creatinine, which is higher than the concentration of 35.2 mM creatinine in mice fed the biotin-deficient diet for 4 weeks.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    625-08-1
  • Formula Weight
    118.13
  • Molecular Formula
    C5H10O3
  • Purity
    >98% (HPLC)
  • Solubility
    Limited solubility
  • SMILES
    CC(C)(O)CC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sabourin PJ, Bieber LL. Arch Biochem Biophys. 1981 Jan;206(1):132-44.
molnova catalog
related products
  • Tozorakimab

    Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting IL-33. It inhibits IL-33 signaling through ST2 and RAGE/EGFR, reduces inflammation and epithelial dysfunction, and can be used to study chronic obstructive pulmonary disease.

  • 6-HYDROXYLAMINOURACI...

    6-HYDROXYLAMINOURACIL is a chemical compound.

  • m-PEG16-alcohol

    m-PEG16-alcohol is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.